Monster Beverage Aktie News

Sales jump, overseas performance, and Big Money buying help Monster Beverage Corporation (MNST) shares rise 58% since February.

Monster Beverage delivered strong Q3 results, driven by robust international growth and improved margins, but remains overvalued. MNST's balance sheet is exceptionally strong, with zero long-term debt and $2.5 billion in cash and short-term investments, providing downside protection. Despite operational improvements, the stock trades at a significant premium to historical and peer valuations, j...

Monster Beverage Corporation ( MNST ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Hilton Schlosberg - CEO & Vice Chairman Mark Astrachan Rob Gehring Conference Call Participants Dara Mohsenian - Morgan Stanley, Research Division Peter Grom - UBS Investment Bank, Research Division Matthew Smith - Stifel, Nicolaus & Company, Incorporated, Research Division Bonnie Herzo...

The energy-drink maker's sales posted a double-digit gain in its latest quarter on increased demand for energy drinks.

2025 Third Quarter Highlights  Record Quarterly Net Sales rise 16.8 percent to $2.20 billion Operating Income increases 40.7 percent to $675.4 million Net Income increases 41.4 percent to $524.5 million Net Income Per Diluted Share increases 41.1 percent to $0.53 per share CORONA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today reported financial resu...

Seascape bought 64,258 shares of Monster Beverage; estimated trade value $4.33 million. The transaction represents 1.2% of 13F reportable AUM as of September 30, 2025.

Beverage veterans Coca-Cola (KO 0.76%) and Monster Beverage (MNST 0.80%) have been business partners since 2014. The soft drink giant made a $2.2 billion investment in Monster back then, while signing an exclusive distribution deal with the energy drink maker.

Monster Beverage delivered record Q2 sales and strong margin expansion, showcasing robust fundamentals and effective pricing power. International growth and structural margin improvements support a healthy long-term outlook, with room for further price increases. Ongoing US market share pressure, potential cost headwinds, and a full valuation at 31x forward PE temper my enthusiasm.